Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 27, 2015 11:12 ET | Source: uniQure

uniQure to Present at the Jefferies 2015 Healthcare Conference

AMSTERDAM, The Netherlands, May 27, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced that its management will present a corporate overview at the...
May 26, 2015 09:30 ET | Source: uniQure

uniQure Announces Closing of Strategic Collaboration with Bristol-Myers Squibb to Develop Gene Therapies for Cardiovascular Disease

AMSTERDAM, the Netherlands, May 26, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced the closing of its strategic collaboration with Bristol-Myers...
April 15, 2015 13:00 ET | Source: uniQure

uniQure Announces Closing of Follow-on Public Offering

AMSTERDAM, The Netherlands, April 15, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced the closing of its previously announced follow-on public...
April 09, 2015 20:00 ET | Source: uniQure

uniQure Announces Pricing of Follow-on Public Offering

AMSTERDAM, Netherlands, April 9, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced the pricing of its follow-on public offering of 3,000,000 ordinary...
April 07, 2015 16:29 ET | Source: uniQure

uniQure Announces Launch of Follow-on Public Offering

Amsterdam, The Netherlands, April 7, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leader in human gene therapy, today announced that it has commenced a follow-on public offering of...
April 06, 2015 08:19 ET | Source: uniQure

uniQure Announces Webcast to Discuss Bristol-Myers Squibb Collaboration

AMSTERDAM, The Netherlands, April 6, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced that at 8:30 EDT/14:30 CET today April 6, 2015, the Company...
April 06, 2015 08:18 ET | Source: uniQure

uniQure Announces Results for Fourth Quarter and Financial Year 2014

AMSTERDAM, The Netherlands, April 6, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced unaudited results for the fourth quarter and year ending...
February 23, 2015 09:38 ET | Source: uniQure

uniQure to Present at the at the Cowen and Company 35th Annual Health Care Conference

Amsterdam, The Netherlands, Feb. 23, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leader in human gene therapy, today announced that its management will present a corporate overview at the...
February 06, 2015 05:48 ET | Source: uniQure

uniQure to Present at the at the Leerink Partners Global Healthcare Conference

AMSTERDAM, the Netherlands, Feb. 6, 2015 (GLOBE NEWSWIRE) -- uniQure to Present at the at the Leerink Partners Global Healthcare Conference Amsterdam, the Netherlands, February 6, 2015 - uniQure N.V....
January 09, 2015 05:08 ET | Source: uniQure

uniQure Appoints Matthew Kapusta as Chief Financial Officer

AMSTERDAM, the Netherlands, Jan. 9, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leader in human gene therapy, today announced that Matthew Kapusta has joined uniQure's management team as...